1. Home
  2. ICO Base
  3. MPLUS

MPLUS

Drugs & Healthcare
Commerce & Retail

Overview

M+plus is a supply chain platform with blockchain method in order to distribute pharmaceuticals and functional foods.

Features

  • Blockchain- decentralized method used to distribute medical products and health food
  • Halal-certified products 
  • One of company's products is "Silk Fibroin." Multi-function nano-level silk fibroin fat absorption product. It is officially permitted by the Malaysian government to be imported.

Crowdsale

Pre-sale
Pre-sale start date 20 Feb 2018
Pre-sale end date 02 Apr 2018
Token Sale
ICO start date 02 Apr 2018
ICO end date 17 May 2018
ICO token supply 1,500,000,000
Legal
ICO Platform 3
Registration Country Malaysia
Registration Year 2005
Token details
Ticker MPL
Type Utility-token
Additional Token Emission No
Accepted Currencies

ETH

Bonus Program
  • From 20th Feb. 100% 280 million tokens
  • From 17th March 80% 126 million tokens
  • From 2nd April 70% 119 million tokens
  • From 17th April 60% 112 million tokens
Token distribution
  • 50% ICO sales
  • 20% Medic Group ownership
  • 10% team ownership
  • 20% Tokens for supply chain development use
Funds allocation
  • 40%  - development of the international distribution platform
  • 20% - Ethernet Reserve
  • 14% - business development dand R&D
  • 8% - Operations
  • 8% - Marketing
  • 5% - Legal affairs
  • 5% - Management cost

Ratings

Type of scores
Score
Status
Hype score Very Low Active

Funding Rounds

Rating Review and Analytics

Investment rating Info NA
Hype score Info Very Low
Risk score Info NA
MPLUS ICO Contacts
Website

Ended

Start ICO 02 Apr 2018
End ICO 17 May 2018
Token MPL
Price 1 MPL = 0.038462 USD
Product Type Marketplace
MVP No product
Registration Country Malaysia
Whitepaper View
MPLUS rating widget
Rating Get this widget
ICOs that might interest you

Status TBA
Hype score High
Risk score Medium
Investment rating Risky


Status TBA
Hype score Medium
Risk score Low
Investment rating Stable


Status TBA
Hype score High
Risk score Medium
Investment rating Stable+


Status Ongoing
Hype score Medium
Risk score Medium
Investment rating Stable+